???global.info.a_carregar???
Dylan Ferreira (DF) is a fourth year PhD student in Biomedical Sciences (ICBAS) at the Portuguese Institute of Oncology of Porto in collaboration with the CIMA Institute (Pamplona, Spain). DF has a Bachelor’s degree in Pathological, Cytological, and Thanatological Anatomy from the School of Health Sciences of Porto (2016) and a Master degree in Medicine and Molecular Oncology from the Faculty of Medicine, University of Porto (2019). Since 2016, DF has been developing his core of research around gastric cancer and different treatment modalities, exploiting gastric cancer glycobiology as a mean to specifically target tumour cells. Concomitantly, has been collaborating in other areas of scientific knowledge such as antibody characterisation, development and clinical implementation of microfluidic devices and biosensors, exosome analysis, circulating tumour cell analysis, vaccine development, among other areas. DF collaborates with at least 8 groups from i3s (University of Porto), Center for Neuroscience and Cell Biology (University of Coimbra), International Iberian Nanotechnology Laboratory (Braga), Faculty of Sports (FADEUP; University of Porto) and NOVA School of Science and Technology (NOVA University of Lisbon), mostly in the scope of post-translational modifications (glycosylation), oncology or biotechnology. Additionally, DF was a visiting researcher at the Institute of Research and Innovation in Health (i3s) of the University of Porto in the Tumour and Microenvironment Interactions Group for more than 5 years. As result, DF has published 2 authored articles and more than 20 articles in international indexed specialized journals, in the fields of oncology, glycobiology, and biotechnology. He has a h-index of 13, an average impact factor of 7, with more than 351 citations in published articles. DF was integrant of one international project financed by the European EuroNanoMed funding platform (ENMed/0005/2015; 2017-2019) and nowadays he integrates five financed pre-clinical and clinical projects [financed by FCT (Foundation for Science and Technology), Swedish pharmaceutical industry and an Australian Biosensors company] at IPO Porto. Since 2022, DF is the PhD student representative on the IPO Porto Research Center Coordinating Committee. In 2020, DF was awarded with a 1-year research grant from National Portuguese League Against Cancer and, in the same year, DF was awarded with a 4-years PhD grant from FCT. Between 2017 and 2024, he was invited to give lectures and workshops at the School of Health at Polytechnic Institute of Bragança. More recently, DF integrated the project “Proficient Pathology Lab. Program - PALOP PPLP 1.0” where he had the opportunity to work in loco in several African Countries of Portuguese Official Language (PALOP) to improve the diagnosis of breast cancer on African Countries. Moreover, currently, he is an Invited Assistant Professor at the School of Medicine and Biomedical Sciences and Faculty of Health Sciences of the University Fernando Pessoa.
Identification

Personal identification

Full name
Dylan Ferreira

Citation names

  • Ferreira, Dylan

Author identifiers

Ciência ID
AA12-CF31-3A82
ORCID iD
0000-0001-9224-0121

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Pathology
  • Medical and Health Sciences - Clinical Medicine - Oncology
  • Medical and Health Sciences - Clinical Medicine - Oncology
  • Medical and Health Sciences - Medical Biotechnology - Health-Related Biotechnology
  • Natural sciences - Biological Sciences - Molecular Biology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2) Upper intermediate (B2)
French Beginner (A1) Intermediate (B1) Beginner (A1) Elementary (A2)
Spanish; Castilian Beginner (A1) Elementary (A2) Beginner (A1) Intermediate (B1)
Education
Degree Classification
2020 - 2024
Ongoing
Ciências Biomédicas (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/09 - 2019/12
Concluded
Medicina e Oncologia Molecular (Mestrado)
Major in Medicina e Oncologia
Universidade do Porto Faculdade de Medicina, Portugal
"Improvement of metastatic gastric cancer management glyco-exploring circulating tumour cells" (THESIS/DISSERTATION)
19
2012/09 - 2016/07
Concluded
Anatomia Patológica, Citológica e Tanatológica (Licenciatura)
Major in Oncologia
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
"Characterization of Mucin 16 expression in bladder cancer: a potential major carrier of sialyl-Tn" (THESIS/DISSERTATION)
15
Affiliation

Science

Category
Host institution
Employer
2018/11/21 - Current Visiting Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2016/03 - Current Researcher (Research) Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2020/01/01 - 2020/12/31 Researcher (Research) Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2017/01/02 - 2019/12/31 Researcher (Research) Grupo de Investigação do Cancro Digestivo, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2016/04/01 - 2016/12/31 Research Trainee (Research) Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Projects

Grant

Designation Funders
2017/02 - 2019/04 Towards a single therapy with a synergistic drug combination against triple negative breast cancer and neuroblastoma by nucleolin-mediated multicellular targeting
Research Fellow
Universidade de Coimbra Centro de Neurociências e Biologia Celular, Portugal
European Commission Seventh Framework Programme for Research and Technological Development
Concluded

Contract

Designation Funders
2022/01/01 - 2024/12/31 RESOLVE: Rational Design of Multivalent Glycocode-Inspired Nanovaccines for Gastric Cancer Immunotherapy
PTDC/MED-OUT/2512/2021
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade de Aveiro, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2021/01/01 - 2024/12/31 Prehabilitation to enhance cancer treatment in patients with adenocarcinoma of the gastroesophageal junction and the stomach
PTDC/SAU-DES/7945/2020
Universidade do Porto Faculdade de Desporto, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto de Astrofísica e Ciências do Espaço, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2023/03/01 - 2024/08/31 REVERENT: PRE-CLINICAL VALIDATION OF A GLYCOCODE-INSPIRED VACCINE FOR BLADDER CANCER IMMUNOTHERAPY
2022.03621.PTDC
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2019/01/01 - 2019/12/31 Centro de Investigação do Instituto Português de Oncologia do Porto
UID/DTP/00776/2019
UID/DTP/04750/2019
UIDB/04750/2020
UIDB/00776/2020
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade do Porto Instituto de Saúde Pública, Portugal

Universidade do Porto Unidade de Investigação em Epidemiologia, Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2020 - Current GlycoSensor: Pre-Clinical Validation of a Point-of-Care Biosensor for Cancer Detection in Whole Blood Based on Abnormal Glycosylation
LUB0001
Researcher
2018/06/15 - Current Synergistic antitumor effect of combined laser thermotherapy and immunomodulators in malignant melanoma
001Laserthermia-EPTG-IPO
Researcher
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Clinical Laserthermia Systems AB
Ongoing
Outputs

Publications

Conference poster
  1. Dourado-Gonçalves, Martina; Freitas, Rui; Ferreira, Dylan; Relvas-Santos, Marta; Paulo, Paula; Santos, Lúcio Lara; Andreia Filipa Ferreira Peixoto; Ferreira, José Alexandre. "Decoding the Functional Glycoproteomic Role of Aberrantly Expressed Short-Chain O-Glycans on Gastric Cancer Cells". Paper presented in Encontro Ciência 2024, 2024.
  2. Peixoto, Andreia; Miranda, Andreia; Ferreira, Dylan; Freitas, Rui; Relvas-Santos, Marta; Ferreira, Eduardo; Cotton, Sofia; et al. "Definindo o papel da glicosilação na agressividade do cancro de bexiga: Impacto do microambiente tumoral". Paper presented in IPO-Porto Summit, 2024.
  3. Soares, Janine; Ferreira, Dylan; Miranda, Andreia; Relvas-Santos, Marta; Brandão, Andreia; Freitas, Rui; Ferreira, Eduardo; et al. "Glycosylation as a driver of Colorectal cancer aggressiveness". Paper presented in 1st Young Researchers¿s Day, 2023.
  4. Ferreira, Eduardo; Freitas, Rui; Miranda, Andreia; Ferreira, Dylan; Relvas-Santos, Marta; Castro, Flávia; Palmeira, Carlos; et al. "A Targeted and Self-Adjuvated PLGA MUC16-Tn Nanoglycovaccine Candidate for Cancer Immunotherapy". Paper presented in 1st Young Researcher's Day, 2023.
  5. Santos, Beatriz; Ferreira, Dylan; Relvas-Santos, Marta; Peixoto, Andreia; Santos, Lúcio; Ferreira, José. "Unravelling the glycomics signature of formalin-fixed paraffin-embedded gastric cancer tissues". Paper presented in 1st Young Researcher's Day, 2023.
  6. Dourado-Gonçalves, Martina; Rui Filipe Neves Freitas; Ferreira, Dylan; Relvas-Santos, Marta; Paulo, Paula; Lúcio Lara Santos. "Functional Glycoproteomics Characterization of Gastric Cancer Cells Expressing Immature O-Glycans". Paper presented in 1st Young Researcher's Day, 2023.
  7. Freitas, Rui; Miranda, Andreia; Ferreira, Dylan; Relvas-Santos, Marta; Castro, Flávia; Ferreira, Eduardo; Gaiteiro, Cristiana; et al. "Pre-clinical Validation of a Multivalent CD44 Glycoconjugate Vaccine for Cancer Immunotherapy". Paper presented in 1st Young Researcher's Day, 2023.
  8. Eiras, Mariana; Gaiteiro, Cristiana; Ferreira, Dylan; Amado, Francisco; Ferreira, José Alexandre. "Clinical and Functional Role of CD44 in Gastric Cancer". Paper presented in 1st Young Researcher's Day, 2023.
  9. Relvas-Santos, Marta; Peixoto, Andreia; Ferreira, Dylan; Lara Santos, Lúcio; Silva, André M. N.; Ferreira, José Alexandre. "Exploiting Glycoengineered Simple Cells and Targeted O-glycoproteomics Towards Bladder Cancer Neoantigens". Paper presented in 1st Young Researchers' Day, 2023.
  10. Cotton, Sofia; Ferreira, Dylan; Relvas-Santos, Marta; Brandão, Andreia; André Moreira Neto da Silva; Lúcio Lara Santos; Ferreira, José Alexandre. "The Secretin Receptor as a Prognostic Marker Carrying E-Selectin Ligands in Colorectal Cancer". Paper presented in 1ST YOUNG RESEARCHERS´DAY, 2023.
  11. Freitas, Rui; Miranda, Andreia; Ferreira, Dylan; Gaiteiro, Cristiana; Ferreira, Eduardo; Relvas-Santos, Marta; Soares, Janine. "Production and pre-clinical evaluation of immunogenic CD44 glycoconjugates: setting the molecular bases for novel multivalent anti-cancer glycovaccines". Paper presented in XLVIII Annual Meeting of the Portuguese Society for Immunology, 2023, 2023.
  12. Miranda, Andreia; Ferreira, Dylan; Freitas, Rui; Relvas-Santos, Marta; Palmeira, Carlos; Paulo, Paula; Castro, Flávia; et al. "Cancer-associated short-chain O-GalNAc glycans induce an immunosupressive bladder cancer phenotype by impairing dendritic cells function. Trabalho apresentado no XLVII Annual Meeting of the Portuguese Society for Immunology.". Paper presented in XLVII Annual Meeting of the Portuguese Society for Immunology, 2022.
  13. Miranda, Andreia; Ferreira, Dylan; Freitas, Rui; Relvas-Santos, Marta; Palmeira, Carlos; Paulo, Paula; Castro, Flávia; et al. "Cancer-associated shor-chain O-GalNAc glycans induce an immunosupressive bladder cancer phenotype by impairing dendritic cells function. Trabalho apresentado no XLVII Annual Meeting of the Portuguese Society for Immunology.". Paper presented in XLVII Annual Meeting of the Portuguese Society for Immunology, 2022.
  14. Miranda, Andreia; Freitas, Rui; Ferreira, Dylan; Andreia F. Peixoto; Ferreira, José Alexandre. "Cancer-associated short-chain O-GalNAc glycans induce an immunosuppressive bladder cancer phenotype by impairing dendritic cells function". Paper presented in XLVII Annual Meeting of the Portuguese Society for Immunology (SPI): At the Crossroads of Human Immunology, 2022.
  15. Carneiro, Adriana; Piairo, Paulina; Teixeira, Alexandra; Ferreira, Dylan; Cotton, Sofia; Rodrigues, Carolina; Chícharo, Alexandre; et al. "Microfluidic-based Isolation of Circulating Tumour Cells in Gastrointestinal Cancers". Paper presented in VII Liquid Biopsy Symposium, 2022.
  16. Ferreira, Dylan; Freitas, Rui; Fernandes, Elisabete; Gaiteiro, Cristiana; Peixoto, Andreia; Cotton, Sofia; Palmeira, Carlos; et al. "Nucleolin-SLeA as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells: a flow cytometry-assisted approach". Paper presented in XVII Congress of the Iberian Society of Cytometry, 2021.
  17. Carneiro, Adriana; Piairo, Paulina; Teixeira, Alexandra; Ferreira, Dylan; Cotton, Sofia; Rodrigues, Carolina; Chícharo, Alexandre; et al. "Microfluidic-based Isolation of Gastrointestinal Circulating Tumour Cells". Paper presented in EuroNanoForum (online), 2021.
  18. Cotton, Sofia; Jotamo Come; Ferreira, Dylan; Fernandes, Elisabete; Carla Carrilho; Santos, Lúcio. "Molecular profiling of squamous cell carcinoma of the esophagus in Mozambique: a genoproteomic-assisted approach to improve oncologic care in Africa". Paper presented in Virtual Cancer Genomics Conference: ¿African genomic diversity: A roadmap to global equity in cancer control¿, 2021.
Journal article
  1. Eiras, Mariana; Soares, Janine; Ferreira, Dylan; Santos, Daniela A. R.; Relvas-Santos, Marta; Santos, Beatriz; Gonçalves, Martina; et al. "Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer". International Journal of Molecular Sciences 25 7 (2024): 3722. http://dx.doi.org/10.3390/ijms25073722.
    10.3390/ijms25073722
  2. Freitas, Rui; Ferreira, Eduardo; Miranda, Andreia; Ferreira, Dylan; Relvas-Santos, Marta; Castro, Flávia; Santos, Beatriz; et al. "Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy". ACS Nano (2024):
    Published
  3. Ferreira, Eduardo; Ferreira, Dylan; Relvas-Santos, Marta; Freitas, Rui; Soares, Janine; Azevedo, Rita; Afonso, Luís Pedro; et al. "Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer". International Journal of Molecular Sciences 25 6 (2024): 3462. http://dx.doi.org/10.3390/ijms25063462.
    Accepted • 10.3390/ijms25063462
  4. Freitas, Rui; Miranda, Andreia; Ferreira, Dylan; Relvas-Santos, Marta; Castro, Flávia; Ferreira, Eduardo; Gaiteiro, Cristiana; et al. "A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy". Journal of Controlled Release 367 (2024): 540-556. http://dx.doi.org/10.1016/j.jconrel.2024.01.065.
    10.1016/j.jconrel.2024.01.065
  5. Freitas, Rui; Miranda, Andreia; Ferreira, Dylan; Relvas-Santos, Marta; Castro, Flávia; Ferreira, Eduardo; Gaiteiro, Cristiana; et al. "A Multivalent CD44 Glycoconjugate Vaccine for Cancer Immunotherapy". Biomaterials (2024):
    Under revision
  6. Freitas, Rui; Ferreira, Eduardo; Miranda, Andreia; Ferreira, Dylan; Relvas-Santos, Marta; Castro, Flávia; Santos, Beatriz; et al. "Targeted and Self-Adjuvated PLGA MUC16-Tn Nanoglycovaccine Candidate for Cancer Immunotherapy". ACS Nano (2024): http://dx.doi.org/10.1021/acsnano.3c12487.
    Submitted • 10.1021/acsnano.3c12487
  7. Cotton, Sofia; Ferreira, Dylan; Relvas-Santos, Marta; Brandão, Andreia; Luis Afonso; Miranda, Andreia; Ferreira, Eduardo; et al. "E-selectin Affinity Glycoproteomics Reveals Neuroendocrine Proteins and the Secretin Receptor as a Poor Prognosis Signature in Colorectal Cancer". (2024):
    Submitted
  8. Borges, Pamela CC; Spencer, Hirondina B; Barbosa, Carla; Costa, Victor; Furtado, Antónia; Conceição Leal, Maria; Lopes, Carlos; et al. "XPERT® breast cancer STRAT4 as an alternative method of identifying breast cancer phenotype in Cape Verde (preliminary results)". ecancermedicalscience 17 (2023): http://dx.doi.org/10.3332/ecancer.2023.1530.
    10.3332/ecancer.2023.1530
  9. Carneiro, Adriana; Piairo, Paulina; Teixeira, Alexandra; Ferreira, Dylan; Cotton, Sofia; Rodrigues, Carolina; Chícharo, Alexandre; et al. "Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients". Cells 11 3 (2022): 376. http://dx.doi.org/10.3390/cells11030376.
    10.3390/cells11030376
  10. Gaiteiro, Cristiana; Soares, Janine; Relvas-Santos, Marta; Peixoto, Andreia; Ferreira, Dylan; Paulo, Paula; Brandão, Andreia; et al. "Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion". Theranostics 12 7 (2022): 3150-3177. http://dx.doi.org/10.7150/thno.67409.
    10.7150/thno.67409
  11. Peixoto, Andreia; Ferreira, Dylan; Azevedo, Rita; Freitas, Rui; Fernandes, Elisabete; Relvas-Santos, Marta; Gaiteiro, Cristiana; et al. "Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer". Journal of Experimental & Clinical Cancer Research 40 1 (2021): 191. http://dx.doi.org/10.1186/s13046-021-01988-6.
    In press • 10.1186/s13046-021-01988-6
  12. Xavier, Cristina P.R.; Castro, Inês; Caires, Hugo R.; Ferreira, Dylan; Cavadas, Bruno; Pereira, Luisa; Santos, Lúcio L.; Oliveira, Maria J.; Vasconcelos, M. Helena. "Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine". Cancer Letters 501 (2021): 210-223. http://dx.doi.org/10.1016/j.canlet.2020.11.013.
    10.1016/j.canlet.2020.11.013
  13. Cotton, Sofia; Ferreira, Dylan; Soares, Janine; Peixoto, Andreia; Relvas-Santos, Marta; Azevedo, Rita; Piairo, Paulina; et al. "Target Score - A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness". International Journal of Molecular Sciences 22 4 (2021): 1664. http://dx.doi.org/10.3390/ijms22041664.
    10.3390/ijms22041664
  14. Carvalho, Sandra; Abreu, Catarina M.; Ferreira, Dylan; Lima, Luís; Ferreira, José A.; Santos, Lúcio L.; Ribeiro, Ricardo; et al. "Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies". Frontiers in Oncology 10 (2020): http://dx.doi.org/10.3389/fonc.2020.01774.
    10.3389/fonc.2020.01774
  15. Fernandes, Elisabete; Freitas, Rui; Ferreira, Dylan; Soares, Janine; Azevedo, Rita; Gaiteiro, Cristiana; Peixoto, Andreia; et al. "Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells". Cancers 12 4 (2020): 861. http://dx.doi.org/10.3390/cancers12040861.
    Published • 10.3390/cancers12040861
  16. Fernandes, Elisabete; Sores, Janine; Cotton, Sofia; Peixoto, Andreia; Ferreira, Dylan; Freitas, Rui; Reis, Celso A.; Santos, Lúcio Lara; Ferreira, José Alexandre. "Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology". Theranostics 10 11 (2020): 4903-4928. http://dx.doi.org/10.7150/thno.42480.
    Published • 10.7150/thno.42480
  17. Carvalho, Sandra; Abreu, Catarina M; Ferreira, Dylan; Lima, Luís; Ferreira, José Alexandre; Ribeiro, Ricardo; Grenha, Vânia; et al. "Microfluidic-isolation of exfoliated tumor cells from urine: Sialyl-Tn as a new urinary biomarker in bladder cancer". Frontiers (2020):
    Submitted
  18. Fernandes, Elisabete; Ferreira, Dylan; Peixoto, Andreia; Freitas, Rui; Relvas-Santos, Marta; Palmeira, Carlos; Martins, Gabriela; et al. "Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential". International Journal of Pharmaceutics 570 (2019): 118646. http://dx.doi.org/10.1016/j.ijpharm.2019.118646.
    Published • 10.1016/j.ijpharm.2019.118646
  19. Neves, Manuel; Azevedo, Rita; Lima, Luís; Oliveira, Marta I.; Peixoto, Andreia; Ferreira, Dylan; Soares, Janine; et al. "Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications". New Biotechnology 49 (2019): 77-87. http://dx.doi.org/10.1016/j.nbt.2018.09.004.
    Published
  20. Carrascal, M.A.; Silva, M.; Ferreira, J.A.; Azevedo, R.; Ferreira, D.; Silva, A.M.N.; Ligeiro, D.; et al. "A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer". Biochimica et Biophysica Acta (BBA) - General Subjects 1862 9 (2018): 2069-2080. http://dx.doi.org/10.1016/j.bbagen.2018.05.013.
    Published
  21. Loureiro, Liliana R.; Sousa, Diana P.; Ferreira, Dylan; Chai, Wengang; Lima, Luís; Pereira, Carina; Lopes, Carla B.; et al. "Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids". Scientific Reports 8 1 (2018): http://dx.doi.org/10.1038/s41598-018-30421-w.
    Published
  22. Azevedo, Rita; Soares, Janine; Gaiteiro, Cristiana; Peixoto, Andreia; Lima, Luís; Ferreira, Dylan; Relvas-Santos, Marta; et al. "Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer". Talanta 184 (2018): 347-355. http://dx.doi.org/10.1016/j.talanta.2018.03.028.
    Published
  23. Lima, Luís; Neves, Manuel; Oliveira, Marta I.; Dieguez, Lorena; Freitas, Rui; Azevedo, Rita; Gaiteiro, Cristiana; et al. "Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases". Urologic Oncology: Seminars and Original Investigations 35 12 (2017): 675.e1-675.e8. http://dx.doi.org/10.1016/j.urolonc.2017.08.012.
    Published • 10.1016/j.urolonc.2017.08.012
  24. Cotton, Sofia; Azevedo, Rita; Gaiteiro, Cristiana; Ferreira, Dylan; Lima, Luís; Peixoto, Andreia; Fernandes, Elisabete; et al. "Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours". Molecular Oncology 11 8 (2017): 895-912. http://dx.doi.org/10.1002/1878-0261.12035.
    Published • 10.1002/1878-0261.12035
Preprint
  1. Andreia Peixoto; Dylan Ferreira; Andreia Miranda; Marta Relvas-Santos; Rui Freitas; Tim S. Veth; Andreia Brandao; et al. "Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells". 2023. https://doi.org/10.1101/2023.10.21.561355.
    10.1101/2023.10.21.561355
Thesis / Dissertation
  1. Dylan Gomes Ferreira. "Improvement of metastic gastric cancer management glyco- exploring circulating tumour cells". Master, Universidade do Porto Faculdade de Medicina, 2019. https://hdl.handle.net/10216/124721.

Intellectual property

Patent
  1. Ferreira, José Alexandre; da Silva, A.M.N.; Freitas, Rui; Santos, Lúcio; Relvas-Santos, Marta; Gaiteiro, Cristiana; Peixoto, Andreia; et al. 2021. "CD44 GLYCOEPITOPES AND CHIMERIC VACCINE GLYCOCONJUGATES FOR CANCER THERAPY AND SYNTHESIS METHODS THEREOF".
    Pending

Other

Other output
  1. Metabolomics, Transcriptomics and Functional Glycomics Reveals Bladder Cancer Cells Plasticity and Enhanced Aggressiveness Facing Hypoxia and Glucose Deprivation. 2021. Andreia Peixoto; Rui Freitas; Dylan Ferreira; Marta Relvas-Santos; Paula Paulo; Marta Cardoso; Janine Soares; et al. https://doi.org/10.1101/2021.02.14.431133.
    10.1101/2021.02.14.431133
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2019/01 Poster conference: "Microfluidic-isolation of exfoliated tumor cells from urine: Sialyl-Tn as a new urinary biomarker in bladder cancer" NanoGateway Winter School 2019: Nanotechnology for Therapy and Diagnostics
International Iberian Nanotechnology Laboratory (Braga, Portugal)
2018/11 Poster conference: "Identification of a novel urinary biomarker for bladder cancer via microfluidic immunoassays" 1st Annual INL Research Symposium
International Iberian Nanotechnology Laboratory (Braga, Portugal)
2018/06/07 Improvement of metastatic gastric cancer management glyco-exploring circulating tumour cells Theoretical class
Escola Superior de Saúde, Instituto Politécnico de Bragança (Bragança, Portugal)
2018/05/11 Expression of nucleolin in normal and tumor tissues: quantification and definition of criteria as possible biomarker for future clinical development 3rd ASPIC congress
Associação Portuguesa de Investigação em Cancro (Lisboa, Portugal)
2018/03/02 Histology: from A to Z - Practical Component Curso Intensivo de Histologia Aplicada
Instituto Politécnico de Bragança, Escola Superior de Saúde (Bragança, Portugal)
2018/02/22 Histology: from A to Z - Theoretical Component Curso Intensivo de Histologia Aplicada
Instituto Politécnico de Bragança, Escola Superior de Saúde (Bragança, Portugal)
2018/02/15 Fundamentos básicos de Biologia Molecular aplicada à investigação Theoretical class
Escola Superior de Saúde, Instituto Politécnico de Bragança (Bragança, Portugal)
2018/01 Poster Conference: "Exploring liquid biopsy and glycosylation for early detection of bladder cancer" III Simposio Biopsia Líquida
Universidad Francisco de Vitoria (Santiago de Compostela, Spain)
2018 Poster Conference: "Exploring the CA19-9 glycoproteome of Borrman Type IV advanced gastric cancer for guided therapeutics" 29th International Carbohydrate Symposium - ICS 2018
International Carbohydrate Organisation (Lisboa, Portugal)
2017/10/26 Princípios básicos de histologia - desmistificando os principais tecidos e componentes Theoretical class
Escola Superior de Saúde, Instituto Politécnico de Bragança (Bragança, Portugal)

Event organisation

Event name
Type of event (Role)
Institution / Organization
2018/05/10 - 2018/05/11 Co-organisor of the workshop entitled “The importance of biomarker validation to increase success in cancer drug development and approval” (2018/05/10 - 2018/05/11)
Workshop (Co-organisor)
Associação Portuguesa de Investigação em Cancro, Portugal
2016/04/14 - 2016/04/14 Organization of event "QUALIFICA 2016" (2016/04/14 - 2016/04/14)
Exhibition (Co-organisor)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2015/03/13 - 2015/03/14 Participation in the organization of the event and technical support during the event (2015/03/13 - 2015/03/14)
Symposium (Member of the Organising Committee)
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal

Event participation

Activity description
Type of event
Event name
Institution / Organization
2018/09/28 - 2018/09/28 Attendance to GICD Academy Course
Other
GICD Academy 2018: Early Phase Clinical Trials
Grupo de Investigação do Cancro Digestivo, Portugal
2018/05/26 - 2018/05/28 Attendance to congress
Congress
XVIII Congresso Técnico de Anatomia Patológica
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2018/04/01 - 2018/04/02 Attendance to international congress
Congress
3rd ASPIC International Congress
Associação Portuguesa de Investigação em Cancro, Portugal
2017/07/07 - 2017/07/07 Attendance to metting
Conference
2017 1st Precision Medicine in Immuno-Oncology Meeting
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2017/07/07 - 2017/07/07 Attendance to pre-meeting course
Workshop
Pre-meeting course: 2017 1st Precision Medicine in Immuno-Oncology Meeting
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2017/05/19 - 2017/05/19 Attendance to meeting
Meeting
2nd Precision Oncology Meeting
Grupo de Investigação do Cancro Digestivo, Portugal
2016/04/01 - 2016/04/02 Attendance to symposium
Symposium
VI Simpósio Técnico de Anatomia Patológica - Novos Temas, Novos Caminhos
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2015/05/23 - 2015/05/23 Attendance to meeting
Other
V Reunião de Citologia
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2015/03/13 - 2015/03/14 Attendance to symposium
Symposium
V Simpósio de Anatomia Patológica - Evolução e Novas Perspectivas
Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2015/01/23 - 2015/01/23 Workshop in Legal Medicine
Workshop
Workshop de Medicina Legal - "Cena do Crime"
Prof. José Pinto da Costa - Centro Médico-Legal, Portugal
2013 - 2013 Attendance to "XIII Curso de Introdução à Medicina Legal e outras Ciências Forenses" - Theoretical and practical component (autopsy)
Other
XIII Curso de Introdução à Medicina Legal e outras Ciências Forenses
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
Distinctions

Award

2024 2nd Best Oral Presentation
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2023 Menção Honrosa - Melhor Poster

Other distinction

2020 Cover of Theranostics
2020 Oncology Research Scholarship
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2020 PhD grant
Fundação para a Ciência e a Tecnologia, Portugal